semaglutide patent expiration semaglutide patent expiry date us As the patents on semaglutide, a popular diabetes and anti-obesity drug Massive Rs 50,000 Cr Opportunity
Description
The MHRA has updated its GLP-1 guidance due to a risk of the rare occurence of NAION among semaglutide patients
Studies show it can help heart disease, sleep apnea, addiction and even brain health
PlexusDx explains the risks, drug interactions, and why dual-mechanism GLP-1 therapy may offer a safer personalized path forward
In our recent Nature paper, over 27,000 consented 23andMe research
Improvement in care, especially in early stages, is crucial
Hot take: GLP-1 spend doesnt have to break the budget So what are large employers missing
